PHAZE 4 Medical buys Aledo Consulting to widen market access reach

PHAZE 4 Medical has acquired Aledo Consulting to expand its market access capabilities across laboratory diagnostics, digital health, medical devices and durable medical equipment. The deal pairs two longtime collaborators as healthcare companies face more complex reimbursement demands.

Why it matters: - The combined firm will offer broader market access support at a time when healthcare companies need earlier and more detailed reimbursement planning. - The expanded platform is designed to help clients move from product development to commercial adoption faster. - The new entity adds capability in medical devices and durable medical equipment, alongside existing strengths in laboratory diagnostics and digital health.

What happened: - PHAZE 4 Medical announced the acquisition of Aledo Consulting on June 23, 2026. - The transaction creates an expanded market access firm based in Boulder, Colorado. - PHAZE 4 Medical was founded in 2023 by Abby Wright. - Aledo Consulting was founded in Indianapolis by Robert C. McDonald, MD, MBA, a former Medical Director at Anthem.

The details: - PHAZE 4 Medical focuses on fractional market access support, with services that cover coverage, coding, pricing and payment. - The firm works with clients ranging from pre-revenue startups to large organizations. - Its client base has been concentrated in clinical laboratory and digital health. - Aledo Consulting has helped companies build coverage cases for products and services across payer segments. - Aledo Consulting has supported access for hundreds of millions of patients, including in the U.S. and internationally. - The combined teams have more than 20 years of collaboration. - In 2014, the two firms worked together to secure coverage for a diagnostic product for more than 220 million covered lives in 18 months. - The firms say their overlapping expertise and hands-on reimbursement work position the new entity to support healthcare innovators from early strategy through commercial scaling.

Between the lines: - The deal reflects how reimbursement has become a core part of healthcare product development, not just a later-stage commercial task. - The combination also gives PHAZE 4 Medical a deeper bench for clients facing payer, coding and payment hurdles across more product categories. - Abby Wright framed the mission as closing the gap between innovation and adoption, while Robert C. McDonald emphasized access to care depends on products being paid for at scale.

What's next: - The combined firm will continue serving healthcare and life sciences clients with end-to-end market access and reimbursement support. - PHAZE 4 Medical is likely to use the acquisition to broaden its client offerings beyond its core laboratory diagnostics and digital health work. - The company will also lean on the existing relationship between the two teams as it integrates services and expands market reach.

The bottom line: - PHAZE 4 Medical is betting that a larger, more integrated market access practice will help healthcare innovators win coverage faster and turn products into reimbursed businesses more efficiently. - More information